Drug Development
The Indian Bulk Drug Market is Fragmented With Top 10 Companies Contributing 44% of the Market
Published in Medical Letter on the CDC and FDA, June 17th, 2007
Indian bulk drugs market in 2006 was about US$3.29 billion, witnessing a growth of 19% over 2005 at CAGR of 18.81% in the last six years. India ranks 4th in terms of volume, among the top 15 drug manufacturing countries worldwide. Indian companies have the distinction of developing cost-effective technologies for manufacturing bulk drugs and intermediates, conforming to global standards. India has over 80 US FDA approved plants, the second highest in the world.
Indian bulk drug market is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Aging
Researchers Find Deadly Prescription Drug Effects Six Years Before FDA - Bird Flu
Human antibodies protect mice from avian flu - Chemical Warfare
Research Looks to Detect Chemical Warfare Agents - Chronic Myelogenous Leukemia
Dasatinib shows high early response rate as first treatment for chronic myelogenous leukemia - Drug Development
FDA Takes Action to Stop Marketing of Unapproved Timed-Release Guaifenesin Drug Products - Flu Vaccines
FDA Finalizes Guidances for Pandemic and Seasonal Influenza Vaccines - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
